Korea Centers for Disease Control and Prevention (KCDC) chief Jung Eun-kyung emphasized that it is possible to receive the AstraZeneca (AZ) vaccine, which has recently been controversial in Europe. Authorities will monitor the safety of the AstraZeneca vaccine.
At the general meeting of the National Assembly Health and Welfare Committee on the morning of the 17th, Chung Eun-kyung, head of the Korea Centers for Disease Control and Prevention, said, “You can get (AstraZeneca Vaccine). All employees of the Korea Centers for Disease Control and Prevention are also inoculating,” and “I will monitor the safety” to a questionnaire at a general meeting of the National Assembly Health and Welfare Committee.
On the day, Congressman Heo asked Chief Chung, “I will ask you straightforwardly. Is it okay to get AstraZeneca (vaccine)? Is it dangerous?”
This concern came as a result of severe adverse reactions or death due to blood clots after vaccination with a specific serial number AstraZeneca vaccine in Austria and other countries. Starting with Austria, the number of countries that stopped vaccinating the vaccine with the same serial number or the entire vaccine is estimated to be at least 21 countries as of the 16th.
First, the AstraZeneca vaccine used in Korea was produced at the SK Bioscience plant, so no vaccine made in Europe was introduced.
In Korea, there were no cases reported as adverse reactions related to the formation of blood clots. Instead, Chung said, “In one case of death, there is an autopsy finding that a blood clot has occurred, so it is under review,” and “No official results have been reported.”
The authorities plan to refer to the final conclusion of the European Medicines Safety Agency (EMA), which is scheduled to be released on the 18th.
Commissioner Chung said, “Even Europe or the World Health Organization (WHO) has not confirmed the evidence for the association between AstraZeneca and blood clots,” he said.
According to the Corona 19 Vaccination Response Promotion Team, as of 0 o’clock on this day, the cumulative number of vaccinations in Korea who completed the first vaccination was 62,1734.
The number of people who completed the first vaccination by vaccine type was 58,7996 AstraZeneca and 33,383 Pfizer.
After vaccination, the number of suspected adverse reactions reported is 9003, with 252 additional cases from the previous day.
The most common adverse reactions after vaccination were 8898 cases. There were 78 cases of both anaphylactic reactions, 3 cases of anaphylactic shock, and 8 cases of serious suspicion of convulsions or hospitalization in the intensive care unit. The number of death reports is a cumulative 16.
The reporting rate by vaccine is 1.51% for AstraZeneca and 0.38% for Pfizer.
Commissioner Jeong said, “I am well aware that there are currently 16 deaths reported and there is anxiety.”
In addition, Commissioner Chung said, “It is difficult to determine whether or not to be vaccinated for each underlying disease, and it is in a situation that it is necessary to make a decision according to the patient’s condition.” “There is.”
Newsis>
[ⓒ 세계일보 & Segye.com, 무단전재 및 재배포 금지]